Skip to content
NCRI logo alt test Toggle Menu

Main Navigation

  • About us
    • Overview
    • Our Partners
    • Our Team
    • Our Trustees
    • Our Strategy
    • Jobs and Opportunities
  • How We Work
    • NCRI Groups
    • NCRI Networks
    • Proposal Guidance
    • Clinical Trials Units
    • Patients and Carers
    • Early Career Researchers
    • Cancer Research Database
  • Areas of Interest
    • Cancer and Covid-19
    • Health Data and AI
    • Immunotherapy and Immunology
    • Living with and Beyond Cancer
    • Pathology
    • Prevention and Early Diagnosis
    • Radiotherapy
  • News and Events
    • News
    • Events
    • Reports and Publications
Newsletter sign up

Haematological

Filter Posts By:

  • Areas of Interest
    • Cancer Research Funding
    • Clinical Research Delivery
    • COVID-19
    • Health Data and AI
    • Imaging
    • Immunotherapy & Immunology
    • Living With & Beyond Cancer
    • Pathology
    • Patient & Public Involvement
    • Prevention & Early Diagnosis
    • Radiotherapy
    • Training & Retention
  • Cancers
    • Bladder & Renal
    • Brain
    • Breast
    • Children
    • Colorectal
    • Gynaecological
    • Haematological
    • Head & Neck
    • Lung
    • Lymphoma
    • Prostate
    • Sarcoma
    • Skin
    • TYA
    • Upper Gastrointestinal
  • Content
    • Blog
    • Case Study
    • Interviews
    • News
    • Press Releases

Reset Filters

'

Using NCRI data to develop a blood cancer research strategy

'
20 September 2021

NCRI and Blood Cancer UK have used the NCRI Cancer Research Database (CaRD) to analyse the blood cancer funding landscape…

Read More

'

Myeloma UK joins NCRI Partnership

'
27 April 2021

The National Cancer Research Institute (NCRI) is delighted to announce that Myeloma UK, a UK cancer research charity focussing exclusively…

Read More

'

Making informed decisions in the event of myeloma relapse

'
09 September 2020

Treating relapsed myeloma Around 5,700 people are diagnosed with myeloma in the UK each year. As there is no cure…

Read More

'

Pattern of hospital visits offers clue to spotting people at risk of myeloma

'
04 November 2019

A condition that can progress to myeloma could be identified in patients by their unusually frequent hospital visits, according to…

Read More

National Cancer Research Institute (NCRI)

2 Redman Place London E20 1JQ
T: +44 (0)20 3469 8798
E: info@ncri.org.uk

NCRI is a Charitable Incorporated Organisation (registered charity number: 1160609)

  • Terms and Conditions
  • Privacy Policy
  • Newsletter